Stock Scorecard

Stock Summary for Essa Pharma Inc (EPIX) - $1.71 as of 5/8/2025 8:05:22 PM EST

Total Score

12 out of 30

Safety Score

24 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for EPIX

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for EPIX

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for EPIX

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for EPIX

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for EPIX (24 out of 100)

Stock Price Rating (Max of 10) 2
Historical Stock Price Rating (Max of 10) 5
Stock Price Trend (Max of 10) 1
Book Value (Max of 10) 3
Book Value to Price (Max of 10) 8
Analyst Buy Ratings (Max of 5) 0
Analyst Strong Buy Ratings (Max of 5) 0
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 5
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for EPIX

ESSA Pharma Inc. Investors: Please contact the Portnoy Law Firm to recover your losses; March 25, 2025 Deadline to file Lead Plaintiff Motion - ESSA Pharma ( NASDAQ:EPIX ) 3/24/2025 11:33:00 PM
ESSA Pharma Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before March 25, 2025 to Discuss Your Rights - EPIX - ESSA Pharma ( NASDAQ:EPIX ) 3/24/2025 9:35:00 AM
EPIX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that ESSA Pharma Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - ESSA Pharma ( NASDAQ:EPIX ) 3/23/2025 8:00:00 PM
EPIX IMPORTANT DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important March 25 Deadline in Securities Class Action - EPIX - ESSA Pharma ( NASDAQ:EPIX ) 3/23/2025 6:46:00 PM
EPIX DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages ESSA Pharma Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 25 Deadline in Securities Class Action - EPIX - ESSA Pharma ( NASDAQ:EPIX ) 3/20/2025 9:04:00 PM
The Gross Law Firm Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 - EPIX - ESSA Pharma ( NASDAQ:EPIX ) 3/20/2025 4:58:00 PM
ESSA Pharma Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. March 25, 2025 Deadline to file Lead Plaintiff Motion. - ESSA Pharma ( NASDAQ:EPIX ) 3/19/2025 7:56:00 PM
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma - ESSA Pharma ( NASDAQ:EPIX ) 3/19/2025 2:48:00 PM
The Gross Law Firm Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 - EPIX - ESSA Pharma ( NASDAQ:EPIX ) 3/17/2025 6:21:00 PM
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma - ESSA Pharma ( NASDAQ:EPIX ) 3/15/2025 11:23:00 AM

Financial Details for EPIX

Company Overview
Ticker EPIX
Company Name Essa Pharma Inc
Country USA
Description ESSA Pharma Inc., a clinical-stage pharmaceutical company, is focused on developing novel and proprietary therapies for the treatment of prostate cancer. The company is headquartered in Vancouver, Canada.
Sector Name LIFE SCIENCES
Industry Name PHARMACEUTICAL PREPARATIONS
Most Recent Quarter 12/31/2024
Next Earnings Date 8/4/2025

Stock Price History
Last Day Price 1.71
Price 4 Years Ago 14.20
Last Day Price Updated 5/8/2025 8:05:22 PM EST
Last Day Volume 393,479
Average Daily Volume 233,464
52-Week High 7.88
52-Week Low 1.40
Last Price to 52 Week Low 22.14%

Valuation Measures
Trailing PE N/A
Industry PE 30.37
Sector PE 45.26
5-Year Average PE -6.18
Free Cash Flow Ratio 0.81
Industry Free Cash Flow Ratio 18.71
Sector Free Cash Flow Ratio 29.93
Current Ratio Most Recent Quarter 33.12
Total Cash Per Share 2.10
Book Value Per Share Most Recent Quarter 2.68
Price to Book Ratio 0.66
Industry Price to Book Ratio 7.62
Sector Price to Book Ratio 21.41
Price to Sales Ratio Twelve Trailing Months 0.00
Industry Price to Sales Ratio Twelve Trailing Months 89.49
Sector Price to Sales Ratio Twelve Trailing Months 25.24
Analyst Buy Ratings 0
Analyst Strong Buy Ratings 0

Share Statistics
Total Shares Outstanding 44,388,600
Market Capitalization 75,904,506
Institutional Ownership N/A

Dividends
Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement
Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth -7.38%
Reported EPS 12 Trailing Months -0.69
Reported EPS Past Year -0.27
Reported EPS Prior Year -0.70
Net Income Twelve Trailing Months -31,110,430
Net Income Past Year -28,542,821
Net Income Prior Year -26,582,343
Quarterly Revenue Growth YOY 0.00%
5-Year Revenue Growth -36.82%
Operating Margin Twelve Trailing Months 0.00%

Balance Sheet
Total Cash Most Recent Quarter 93,310,889
Total Cash Past Year 103,709,537
Total Cash Prior Year 33,701,912
Net Cash Position Most Recent Quarter 93,290,889
Net Cash Position Past Year 103,709,537
Long Term Debt Past Year 0
Long Term Debt Prior Year 0
Total Debt Most Recent Quarter 20,000
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 128,112,003
Total Stockholder Equity Prior Year 145,627,060
Total Stockholder Equity Most Recent Quarter 118,767,004

Free Cash Flow
Free Cash Flow Twelve Trailing Months -22,467,411
Free Cash Flow Per Share Twelve Trailing Months -0.51
Free Cash Flow Past Year -22,716,199
Free Cash Flow Prior Year -19,781,720

Options
Put/Call Ratio 0.00
Has Options Options Chain
Liquidity Rating None

Technical Analysis
Yahoo Finance Chart Yahoo Finance Chart
MACD 0.04
MACD Signal 0.04
20-Day Bollinger Lower Band 1.52
20-Day Bollinger Middle Band 1.69
20-Day Bollinger Upper Band 1.87
Beta 1.69
RSI 51.79
50-Day SMA 3.54
150-Day SMA 3.98
200-Day SMA 5.56

System
Modified 5/7/2025 11:04:36 PM EST